Immunogenicity and Safety in Healthy Adults of Full-Dose Versus Half Doses of COVID-19 Vaccine (ChAdOx1-S or BNT162b2) or Full-Dose CoronaVac Administered as a Booster Dose after Priming with Coronavac: A Randomized, Observer-Blinded, Controlled Trial Conducted in Indonesia

Eddy Fadlyana; Djatnika Setiabudi; Nina Dwi Putri; Yulia Sofiatin; Hendarsyah Suryadinata; Yovita Hartantri; Hadyana Sukandar; Agnes R. Indrati; Chrysanti Murad; Vivi Setiawaty; Krisna Nur A Pangesti; Pretty Multihartina; Citra Vravita Khrisna; Masayu Riela Ayuninda; Pratama Wicaksana; Aqila Sakina Zhafira; Robert Shinto; Cissy B. Kartasasmita; Kusnandi Rusmil; Sri Rezeki Hadinegoro; Julitasari Sundoro; Emma Watts; Cattram D. Nguyen; Kim Mulholland

SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4185918 issn: 1556-5068

Eddy Fadlyana, Djatnika Setiabudi, Nina Dwi Putri, Yulia Sofiatin, Hendarsyah Suryadinata, Yovita Hartantri, Hadyana Sukandar, Agnes R. Indrati, Chrysanti Murad, Vivi Setiawaty, Krisna Nur A Pangesti, Pretty Multihartina, Citra Vravita Khrisna, Masayu Riela Ayuninda, Pratama Wicaksana, Aqila Sakina Zhafira, Robert Shinto, Cissy B. Kartasasmita, Kusnandi Rusmil, Sri Rezeki Hadinegoro